Three Indian firms launched generic semaglutide after patent expiry for diabetes and obesity treatment Sun Pharma markets Noveltreat and Sematrinity with weekly costs from Rs 750 to Rs 2,000 Zydus Lifesciences offers SEMAGLYN, MASHEMA, and ALTERME in a reusable pen at Rs 2,200 monthly
